Hydroxyzine and Kisqali drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxyzine (hydroxyzine hydrochloride) and Kisqali (ribociclib succinate). Common drug interactions include diarrhoea among females.

The phase IV clinical study analyzes what interactions people have when they take Hydroxyzine and Kisqali. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxyzine?

Hydroxyzine has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 54,069 Hydroxyzine users. Check the latest studies of Hydroxyzine.

What is Kisqali?

Kisqali has active ingredients of ribociclib succinate. eHealthMe is studying from 25,049 Kisqali users. Check the latest studies of Kisqali.

On Jul, 29, 2026

24 people who take Hydroxyzine and Kisqali together, and have interactions are studied.

Hydroxyzine and Kisqali drug interactions.

What are the common drug interactions of Hydroxyzine and Kisqali, by gender? *:

female:

Diarrhoea
Fatigue (feeling of tiredness)
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Discomfort
Dry skin
Dyspepsia (indigestion)
Eating disorder
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
Injection site mass

male:

n/a

What are the common drug interactions of Hydroxyzine and Kisqali, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Death

20-29:

n/a

30-39:

n/a

40-49:

Device related infection
Dyspnoea (difficult or laboured respiration)
Dysstasia (difficulty in standing)
Eye infection
Eye inflammation
Hypersensitivity
Metastases to lung (cancer spreads to lung)
Metastasis (spreadable cancer to other organ from origin)
Mobility decreased (ability to move is reduced)
Muscular weakness (muscle weakness)

50-59:

Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)
Arthralgia (joint pain)
Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
Cardiac disorder
Choking (mechanical obstruction of the flow of air from the environment into the lungs)
Cough
Discomfort
Dizziness

60+:

Bacteraemia (presence of bacteria in the blood)
Hyperglycaemia (high blood sugar)
Pyelonephritis (inflammation of kidney caused by bacteria)
Urinary tract infection
Fatigue (feeling of tiredness)
Full blood count decreased
Neutropenia (an abnormally low number of neutrophils)

What are the existing conditions these people have? *

Breast Cancer: 17 people, 70.83%
Breast Cancer Metastatic: 15 people, 62.50%
Furuncle (infection of the hair follicle): 13 people, 54.17%
Hypersensitivity: 5 people, 20.83%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 5 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyzine and Kisqali?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously